|
Volumn 28, Issue 2, 1999, Pages 412-415
|
Clinical application of argatroban as an anticoagulant for PCPS: Its advantages is reducing the risk of bleeding as determined by hemostatic molecular markers
|
Author keywords
Anticoagulant; Argatroban; Hemostatic molecular markers; Percutaneous cardiopulmonary support (PCPS)
|
Indexed keywords
ANTICOAGULANT AGENT;
ANTITHROMBIN III;
ARGATROBAN;
BETA THROMBOGLOBULIN;
FIBRIN;
FIBRINOGEN;
PROTHROMBIN;
THROMBIN;
THROMBIN ANTITHROMBIN COMPLEX;
THROMBIN INHIBITOR;
THROMBOCYTE FACTOR 4;
ADULT;
AGED;
ANTICOAGULATION;
ASSISTED CIRCULATION;
ASSISTED VENTILATION;
BLEEDING;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
EXTRACORPOREAL CIRCULATION;
FEMALE;
HEMOSTASIS;
HUMAN;
HUMAN CELL;
MALE;
RISK;
THROMBOCYTE ACTIVATION;
THROMBOCYTE COUNT;
|
EID: 0032983387
PISSN: 03000818
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (10)
|